Whitehawk Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2008 | -2,401.6% | -2,401.6% | — |
| FY2009 | 107.5% | 107.5% | — |
| FY2010 | 54.6% | 54.6% | — |
| FY2011 | 39.9% | 39.9% | — |
| FY2012 | 28.6% | 28.6% | -337.5% |
| FY2013 | 23.1% | 23.1% | -326.8% |
| FY2014 | 19.9% | 19.9% | -585.2% |
| FY2015 | 0.0% | 0.0% | -169.7% |
| FY2016 | 19.7% | 19.7% | -708.6% |
| FY2017 | -122.7% | -122.7% | -101.8% |
| FY2018 | -17.7% | -17.7% | -16.2% |
| FY2019 | 255.9% | 255.9% | -58.3% |
| FY2020 | 28.0% | 28.0% | -18.5% |
| FY2021 | -80.7% | -80.7% | -69.7% |
| FY2022 | -38.2% | -38.2% | -32.8% |
| FY2023 | -62.5% | -62.5% | -49.7% |
| FY2024 | -121.4% | -121.4% | -90.6% |
| FY2025 | -15.1% | -15.1% | -13.7% |